Archive for the ‘china retractions’ Category
The author of a 2016 paper has agreed to retract it after an investigation revealed that most of the article came from another research group at the same university.
According to the notice, the author based the majority of his paper on results generated by other scientists without their permission.
Here’s the retraction notice for “Controlled synthesis of magnetic block copolymers for anti-microbial purpose,” published in the Journal of Applied Polymer Science in November and retracted in February: Read the rest of this entry »
Researchers in China have retracted a 2016 cancer imaging paper because they introduced “a plethora of data errors” while preparing the article for submission.
Although the retraction notice provides no details on what these errors are or how exactly they occurred, it does point the finger at the researchers, explaining that the data errors happened as a result of their “negligence.”
Here’s the 2017 retraction notice for “Rituximab-conjugated, doxorubicin-loaded microbubbles as a theranostic modality in B-cell lymphoma,” published November 25, 2016 in Oncotarget: Read the rest of this entry »
Researchers in China have retracted a 2016 paper exploring the replication behaviors of a retrovirus, after discovering that the key results could not be reproduced — possibly because their cell cultures had been contaminated.
The authors also cite a disagreement with a colleague, who they say contributed to the work but does not want to be listed as an author.
Here’s the retraction notice for “Nuclear import of prototype foamy virus transactivator Bel1 is mediated by KPNA1, KPNA6 and KPNA7,” published in the International Journal of Molecular Medicine: Read the rest of this entry »
Sometimes we come across a real head-scratcher.
That happened this week, when we saw a retraction notice for a 2015 paper on gastric cancer in the International Journal of Clinical and Experimental Medicine, which only says the authors “made big mistakes” and contains two fairly significant typos.
Although there’s no sign of a retraction on PubMed, the table of contents for the latest issue of the journal lists the retraction — but includes no hyperlink to the notice. The only way to see it is via a Web cached version. Here’s the text:
One of the retracted papers in the Journal of Neurosurgery (JNS) had multiple problems that were “too extensive to revise,” according to the lengthy retraction notice, relating to issues with authorship, data analyses, and patient enrollment. The notice is signed by first author Hua Liu of the Nanjing Medical University in China.
Liu is also the first author of another recently retracted paper in Frontiers in Neuroscience, pulled for incorrectly categorizing patients.
An oncology journal has decided to retract a 2012 paper on gastric cancer after discovering duplicated data in multiple figures.
According to the retraction notice, the journal’s editorial board received a tip from a reader regarding the potential figure issues. Oncology Reports launched an investigation, which confirmed the allegations. The authors failed to respond to the journal’s multiple requests for more information.
According to the retraction notice in the International Journal of Molecular Medicine (IJMM), the authors intended that the two different papers offered “different research perspectives.”
Meanwhile, the Chinese Medical Journal — which published the same images one month later — has issued an expression of concern (EOC), noting it “should not be considered as a statement regarding the validity of the work.” Both papers describe how cells regulate blood flow to the retina.
Normally, journals choose to retract the most recent paper containing duplicated images, but in this case, the IJMM paper was published online in February 2016, and the Chinese Medical Journal in March.
According to an excerpt from the retraction notice in Genetics and Molecular Research, the journal has “strong reason to believe that the peer review process was [a] failure,” and has alerted the authors’ institutions.
According to the new retraction notice in The Plant Cell, some figures in the paper were manipulated, as well as “inappropriately duplicated and reused from a previous publication.” The authors assert that they believe the conclusions remain valid.
The journal has also issued two corrections that include some of the same authors — including one that cites inappropriate image manipulation.
Zhao Kai, the study’s first author from the Qilu Hospital of Shandong University and Zibo Central Hospital (both in China), took full responsibility for the error.